BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 24874813)

  • 1. Antibiotic resistance-mediated isolation of scaffold-specific natural product producers.
    Thaker MN; Waglechner N; Wright GD
    Nat Protoc; 2014; 9(6):1469-79. PubMed ID: 24874813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying producers of antibacterial compounds by screening for antibiotic resistance.
    Thaker MN; Wang W; Spanogiannopoulos P; Waglechner N; King AM; Medina R; Wright GD
    Nat Biotechnol; 2013 Oct; 31(10):922-7. PubMed ID: 24056948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Culturable rare Actinomycetes: diversity, isolation and marine natural product discovery.
    Subramani R; Aalbersberg W
    Appl Microbiol Biotechnol; 2013 Nov; 97(21):9291-321. PubMed ID: 24057404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New approaches to antimicrobial discovery.
    Lewis K
    Biochem Pharmacol; 2017 Jun; 134():87-98. PubMed ID: 27823963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rare actinomycetes: a potential storehouse for novel antibiotics.
    Tiwari K; Gupta RK
    Crit Rev Biotechnol; 2012 Jun; 32(2):108-32. PubMed ID: 21619453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Marine actinomycetes as an emerging resource for the drug development pipelines.
    Zotchev SB
    J Biotechnol; 2012 Apr; 158(4):168-75. PubMed ID: 21683100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Science of Antibiotic Discovery.
    Lewis K
    Cell; 2020 Apr; 181(1):29-45. PubMed ID: 32197064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycopeptide antibiotic discovery in the genomic era.
    Xu M; Wang W; Wright GD
    Methods Enzymol; 2022; 665():325-346. PubMed ID: 35379441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimizing Small World Initiative service learning by focusing on antibiotics-producing actinomycetes from soil.
    de Groot PWJ; Fernández-Pereira J; Sabariegos R; Clemente-Casares P; Parra-Martínez J; Cid VJ; Moreno DA
    FEMS Microbiol Lett; 2019 Dec; 366(24):. PubMed ID: 31995181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-resistance mechanisms of actinomycetes producing lipid II-targeting antibiotics.
    Stegmann E; Frasch HJ; Kilian R; Pozzi R
    Int J Med Microbiol; 2015 Feb; 305(2):190-5. PubMed ID: 25601631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural product discovery: past, present, and future.
    Katz L; Baltz RH
    J Ind Microbiol Biotechnol; 2016 Mar; 43(2-3):155-76. PubMed ID: 26739136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemical analyses of wasp-associated streptomyces bacteria reveal a prolific potential for natural products discovery.
    Poulsen M; Oh DC; Clardy J; Currie CR
    PLoS One; 2011 Feb; 6(2):e16763. PubMed ID: 21364940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Harnessing Rare Actinomycete Interactions and Intrinsic Antimicrobial Resistance Enables Discovery of an Unusual Metabolic Inhibitor.
    McClung DJ; Du Y; Antonich DJ; Bonet B; Zhang W; Traxler MF
    mBio; 2022 Jun; 13(3):e0039322. PubMed ID: 35608300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ecological Strategies Behind the Selection of Cultivable Actinomycete Strains from the Yucatan Peninsula for the Discovery of Secondary Metabolites with Antibiotic Activity.
    Parera-Valadez Y; Yam-Puc A; López-Aguiar LK; Borges-Argáez R; Figueroa-Saldivar MA; Cáceres-Farfán M; Márquez-Velázquez NA; Prieto-Davó A
    Microb Ecol; 2019 May; 77(4):839-851. PubMed ID: 30761424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Actinomycetes: still a source of novel antibiotics.
    Genilloud O
    Nat Prod Rep; 2017 Oct; 34(10):1203-1232. PubMed ID: 28820533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The re-emerging role of microbial natural products in antibiotic discovery.
    Genilloud O
    Antonie Van Leeuwenhoek; 2014 Jul; 106(1):173-88. PubMed ID: 24923558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endophytic actinomycetes: promising source of novel bioactive compounds.
    Matsumoto A; Takahashi Y
    J Antibiot (Tokyo); 2017 May; 70(5):514-519. PubMed ID: 28270688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platforms for antibiotic discovery.
    Lewis K
    Nat Rev Drug Discov; 2013 May; 12(5):371-87. PubMed ID: 23629505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marcel Faber Roundtable: is our antibiotic pipeline unproductive because of starvation, constipation or lack of inspiration?
    Baltz RH
    J Ind Microbiol Biotechnol; 2006 Jul; 33(7):507-13. PubMed ID: 16418869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding and manipulating antibiotic production in actinomycetes.
    Bibb MJ
    Biochem Soc Trans; 2013 Dec; 41(6):1355-64. PubMed ID: 24256223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.